Journals / E Journal of Cardiovascular Medicine / 2021 / Cilt: 9 - Sayı: 1

Association Between Microalbuminuria and Pulse Pressure Among Patients with Isolated Systolic and Diastolic Hypertension

Pages
39–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Overall, we included 183 patients (58.5% female) with HT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study is to examine the prevalence and predictors of microalbuminuria and to investigate the association between microalbuminuria and pulse pressure among patients with isolated systolic and diastolic hypertension (DH).
📊
Key Findings & Data:Results: Overall, we included 183 patients (58.5% female) with HT.
💡
Conclusion & Impact:Conclusion: This study demonstrated that microalbuminuria in hypertensive patients was independently associated with left atrial size and systolic blood pressure, but not with pulse pressure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: The aim of this study is to examine the prevalence and predictors of microalbuminuria and to investigate the association between microalbuminuria and pulse pressure among patients with isolated systolic and diastolic hypertension (DH). Materials and Methods: In this cross-sectional study, patients with DH and isolated systolic hypertension (ISH) were included. Data including patient age, sex, duration of hypertension (HT), comorbidities, and drugs were recorded. Blood analysis of serum total cholesterol, high D-density lipoprotein (HDL) cholesterol, triglyceride, urea, creatinine, and fasting blood glucose, urinalysis, electrocardiography (ECG), transthoracic echocardiography, exercise stress test (EST), and coronary angiography (if the patient had a positive EST result) were performed. Results: Overall, we included 183 patients (58.5% female) with HT. The patients with ISH had significantly higher pulse pressure, left ventricular (LV) mass, and LV mass index, but had a shorter duration of HT and lower diastolic blood pressure than those with DH. All patients were in sinus rhythm, and there were no ischemic ECG changes. Fifty nine (32.2%) patients had microalbuminuria (MA) (≥20 µg/min). LV mass, left atrial diameter, E/A ratio, systolic blood pressure (SBP), pulse pressure, and frequency of LVH were significantly higher in patients with MA than in patients without MA. The prevalence of angiographically proven atherosclerotic heart disease was similar in patients with and without microalbuminuria. Multivariate binary logistic regression analysis revealed that only systolic pressure and left atrial diameter were independent associates of microalbuminuria. Each 1 mmHg increase in SBP was associated with a 3% increase in the risk of having microalbuminuria (p=0.04). In addition, each 1 mm increase in the diameter of the left atrium increased the risk of having microalbuminuria by 20% (p=0.02). Conclusion: This study demonstrated that microalbuminuria in hypertensive patients was independently associated with left atrial size and systolic blood pressure, but not with pulse pressure.

🔖

Cite This Article

COŞKUN, Ş., CORDAN, J., MEHMETOĞLU, E., SAĞ, S., YEŞİLBURSA, D., SERDAR, O. A., GÜDÜLLÜ, S., AYDINLAR, A. (2021). Association Between Microalbuminuria and Pulse Pressure Among Patients with Isolated Systolic and Diastolic Hypertension. E Journal of Cardiovascular Medicine, Cilt: 9 - Sayı: 1, 39–48. https://ajindex.com/articles/149193

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Basi S, Fesler P, Mimran A, Lewis JB. Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes Care 2008;31:194-201
  2. Segura J, Ruilope LM, Rodicio JL. Microalbuminuria. Clin Exp Hypertens 2004;26:701-7
  3. Yuyun MF, Khaw KT, Luben R, et al. Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil 2004;11:207-13
  4. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-60
  5. Arnlöv J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005;112:969-75
  6. Reboldi G, Gentile G, Angeli F, Verdecchia P. Microalbuminuria and hypertension. Minerva Med 2005;96:261-75
  7. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002;39:445-59
  8. Böhm M, Thoenes M, Danchin N, Bramlage P, La Puerta P, Volpe M. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens 2007;25:2317-24
  9. Aggarwal HK, Jain D, Mor S, Yadav RK, Jain P. Prevalence and Clinical Correlates of Microalbuminuria in Patients with Essential Hypertension - A Tertiary Care Center Cross Sectional Study. J Assoc Physicians India 2018;66:30-4
  10. Mateo-Gavira I, Vílchez-López FJ, García-Palacios MV, Carral-San Laureano F, Jiménez-Carmona S, Aguilar-Diosdado M. Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complications 2016;30:1326-32
  11. Hata J, Fukuhara M, Sakata S, et al. White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study. Hypertens Res 2017;40:937-43
  12. Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG (2000) Pulse pressure and isolated systolic hypertension: association with microalbuminuria. Kidney İnternational 2000;58:1211-8
  13. Xie N, Li X, Zhong Q, et al. Association of systolic blood pressure and pulse pressure with microalbuminuria in treatment-naïve hypertensive patients. Arch Med Sci 2019;15:832-6
  14. Tsakiris A, Doumas M, Lagatoura